The Merck Digital Sciences Studio (MDSS) is a nine-month accelerator that invests in and supports early-stage startups developing digitally enabled technologies for drug discovery, pre-clinical, and clinical development.
Selected startups gain direct access to Merck experts, personalized mentoring from Centech advisors, and a SAFE investment from the Merck Global Health Innovation Fund (GHI), in collaboration with regional partners The Venture Collective (United States) and CQDM (Canada). Through this collaborative approach, MDSS connects innovators, researchers, and industry leaders to accelerate breakthroughs in health technology.
